Edwards Lifesciences Operating Margin 2010-2025 | EW

Current and historical operating margin for Edwards Lifesciences (EW) over the last 10 years. The current operating profit margin for Edwards Lifesciences as of March 31, 2025 is 28.04%.
Edwards Lifesciences Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2025-03-31 $5.52B $1.43B 25.81%
2024-12-31 $5.44B $1.38B 25.35%
2024-09-30 $5.08B $1.36B 26.76%
2024-06-30 $4.97B $1.38B 27.66%
2024-03-31 $4.88B $1.27B 26.02%
2023-12-31 $5.01B $1.31B 26.12%
2023-09-30 $4.43B $1.22B 27.46%
2023-06-30 $4.51B $1.25B 27.79%
2023-03-31 $4.58B $1.45B 31.60%
2022-12-31 $4.46B $1.50B 33.58%
2022-09-30 $5.36B $1.68B 31.23%
2022-06-30 $5.36B $1.66B 31.06%
2022-03-31 $5.36B $1.75B 32.57%
2021-12-31 $5.23B $1.69B 32.30%
2021-09-30 $5.10B $1.67B 32.72%
2021-06-30 $4.93B $1.64B 33.19%
2021-03-31 $4.48B $0.92B 20.63%
2020-12-31 $4.39B $0.90B 20.45%
2020-09-30 $4.37B $0.86B 19.62%
2020-06-30 $4.32B $0.79B 18.35%
2020-03-31 $4.48B $1.23B 27.45%
2019-12-31 $4.35B $1.15B 26.38%
2019-09-30 $4.15B $0.83B 20.01%
2019-06-30 $3.97B $0.79B 19.82%
2019-03-31 $3.82B $0.77B 20.15%
2018-12-31 $3.72B $0.75B 20.11%
2018-09-30 $3.64B $1.06B 29.13%
2018-06-30 $3.55B $1.04B 29.24%
2018-03-31 $3.45B $1.04B 30.02%
2017-12-31 $3.44B $1.09B 31.74%
2017-09-30 $3.32B $0.96B 28.86%
2017-06-30 $3.23B $0.92B 28.58%
2017-03-31 $3.15B $0.89B 28.25%
2016-12-31 $2.96B $0.78B 26.43%
2016-09-30 $2.87B $0.79B 27.46%
2016-06-30 $2.74B $0.75B 27.27%
2016-03-31 $2.60B $0.68B 26.14%
2015-12-31 $2.49B $0.64B 25.78%
2015-09-30 $2.44B $0.62B 25.32%
2015-06-30 $2.43B $0.59B 24.34%
2015-03-31 $2.39B $0.56B 23.60%
2014-12-31 $2.32B $0.49B 21.23%
2014-09-30 $2.24B $0.47B 21.03%
2014-06-30 $2.13B $0.45B 21.00%
2014-03-31 $2.07B $0.46B 21.97%
2013-12-31 $2.05B $0.47B 23.12%
2013-09-30 $2.02B $0.49B 24.16%
2013-06-30 $1.97B $0.48B 24.19%
2013-03-31 $1.94B $0.45B 23.03%
2012-12-31 $1.90B $0.42B 22.12%
2012-09-30 $1.82B $0.36B 20.01%
2012-06-30 $1.78B $0.33B 18.44%
2012-03-31 $1.73B $0.31B 17.77%
2011-12-31 $1.68B $0.30B 17.87%
2011-09-30 $1.64B $0.29B 17.92%
2011-06-30 $1.58B $0.30B 19.09%
2011-03-31 $1.51B $0.30B 19.85%
2010-12-31 $1.45B $0.29B 19.70%
2010-09-30 $1.40B $0.27B 19.19%
2010-06-30 $1.38B $0.26B 18.78%
2010-03-31 $1.35B $0.25B 18.37%
2009-12-31 $1.32B $0.24B 18.07%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $44.083B $5.440B
Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care.
Stock Name Country Market Cap PE Ratio
Intuitive Surgical (ISRG) United States $183.575B 81.48
Thermo Fisher Scientific (TMO) United States $152.039B 18.50
Alcon (ALC) Switzerland $42.518B 28.73
IDEXX Laboratories (IDXX) United States $42.037B 48.87
DexCom (DXCM) United States $32.149B 50.30
IQVIA Holdings (IQV) United States $27.142B 15.43
Mettler-Toledo (MTD) United States $24.013B 29.24
STERIS (STE) Ireland $23.741B 26.13
Waters (WAT) United States $20.370B 29.20
SONOVA HOLDING (SONVY) Switzerland $18.723B 0.00
Hologic (HOLX) United States $14.429B 15.78
Sysmex ADR (SSMXY) Japan $10.852B 30.58
Penumbra (PEN) United States $9.933B 79.32
Masimo (MASI) United States $8.740B 32.51
Globus Medical (GMED) United States $7.974B 18.99
Glaukos (GKOS) United States $5.577B 0.00
Teleflex (TFX) United States $5.300B 8.83
TransMedics (TMDX) United States $4.833B 104.38
Integer Holdings (ITGR) United States $4.128B 21.63
PROCEPT BioRobotics (PRCT) United States $3.355B 0.00
LivaNova (LIVN) United Kingdom $2.495B 14.77
Nihon Kohden (NHNKY) Japan $2.264B 22.90
Veracyte (VCYT) United States $2.071B 29.27
Elekta AB (EKTAY) Sweden $1.901B 17.30
Alphatec Holdings (ATEC) United States $1.617B 0.00
Tandem Diabetes Care (TNDM) United States $1.383B 0.00
Artivion (AORT) United States $1.206B 114.92
Pulse Biosciences (PLSE) United States $1.061B 0.00
OPKO Health (OPK) United States $1.055B 0.00
Integra LifeSciences Holdings (IART) United States $0.945B 5.12
Beta Bionics (BBNX) United States $0.828B 0.00
SiBone (SIBN) United States $0.742B 0.00
IRadimed (IRMD) United States $0.740B 37.75
RxSight (RXST) United States $0.577B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.560B 8.80
Delcath Systems (DCTH) United States $0.534B 0.00
Mesa Laboratories (MLAB) United States $0.530B 12.29
OrthoPediatrics (KIDS) United States $0.514B 0.00
AxoGen (AXGN) United States $0.444B 0.00
AngioDynamics (ANGO) United States $0.433B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.431B 0.00
NeuroPace (NPCE) United States $0.363B 0.00
Pacific Biosciences Of California (PACB) United States $0.360B 0.00
Treace Medical Concepts (TMCI) United States $0.357B 0.00
Semler Scientific (SMLR) United States $0.330B 9.06
ClearPoint Neuro (CLPT) United States $0.323B 0.00
908 Devices (MASS) United States $0.262B 0.00
Neuronetics (STIM) United States $0.249B 0.00
Tactile Systems Technology (TCMD) United States $0.229B 13.93
Sight Sciences (SGHT) United States $0.214B 0.00
Alpha Tau Medical (DRTS) Israel $0.213B 0.00
Spectral Diagnostics (EDTXF) Canada $0.183B 0.00
Biosig Technologies (BSGM) United States $0.174B 0.00
Inogen (INGN) United States $0.168B 0.00
Anteris Technologies Global (AVR) Australia $0.158B 0.00
Rapid Micro Biosystems (RPID) United States $0.156B 0.00
CVRx (CVRX) United States $0.153B 0.00
LENSAR (LNSR) United States $0.147B 0.00
Lucid Diagnostics (LUCD) United States $0.140B 0.00
Accuray (ARAY) United States $0.126B 0.00
Atossa Genetics (ATOS) United States $0.107B 0.00
Monogram Orthopaedics (MGRM) United States $0.095B 0.00
Microbot Medical (MBOT) United States $0.085B 0.00
Sensus Healthcare (SRTS) United States $0.079B 48.20
EnVVeno Medical (NVNO) United States $0.076B 0.00
InspireMD (NSPR) United States $0.071B 0.00
EDAP TMS S.A (EDAP) France $0.064B 0.00
Hyperfine (HYPR) United States $0.056B 0.00
Spectral AI (MDAI) United States $0.050B 0.00
Vicarious Surgical (RBOT) United States $0.047B 0.00
Precision Optics (POCI) United States $0.037B 0.00
Baird Medical Investment Holdings (BDMD) $0.036B 0.00
DarioHealth (DRIO) United States $0.030B 0.00
Envoy Medical (COCH) United States $0.029B 0.00
NexGel (NXGL) United States $0.020B 0.00
Adagio Medical Holdings (ADGM) United States $0.017B 0.00
WORK Medical Technology Group (WOK) China $0.012B 0.00
PAVmed (PAVM) United States $0.011B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.009B 0.00
Ekso Bionics Holdings (EKSO) United States $0.009B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.008B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
ReShape Lifesciences (RSLS) United States $0.006B 0.00
Check-Cap (CHEK) Israel $0.004B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
Nanovibronix (NAOV) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Nuwellis (NUWE) United States $0.001B 0.00
Accelerate Diagnostics (AXDX) United States $0.001B 0.00
Helius Medical Technologies (HSDT) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $0.000B 16.26